Fragmentation-based molecular annotations are the gold standard in high-confidence biomarker identification using mass spectrometry. The new iprm-PASEF workflow integrates CCS-enabled MALDI Imaging of lipids with a targeted MS/MS imaging approach that allows spatial fragmentation and analysis of multiple targets in a single acquisition. The workflow includes a fully integrated pipeline within our software ecosystem to generate accurate identifications with spatial fidelity.
Key Learning Objectives:
Fragmentation based MALDI Imaging capabilities
iprm-PASEF workflow for the timsTOF fleX
Fragmentation based annotation pipeline using SCiLS™ Lab
Who should attend:
Michael Becker, Ph.D., Principal Scientist DMPK, Boehringer Ingelheim Pharma GmbH & Co KG, Mainz, Germany
Arne Behrens, Ph.D., Application Specialist in MALDI Imaging, Bruker Daltonics GmbH & Co. KG, Bremen, Germany
Björn Wendik, Ph.D., Business Development Manager, Bruker Daltonics GmbH & Co. KG, Bremen, Germany
For Research Use Only. Not for use in clinical diagnostic procedures.